Risultati di ricerca
First half of 2023 sees ICON recognised for CRO excellence, alongside industry awards as an employer of choice and for its creative and digital services. Dublin, Ireland – 13 July 2023 – ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has received positive recognition from leading ...
ICON and You. Working in a way that goes beyond the traditional CRO. At ICON our reputation is built on enduring partnerships that are driven to advance medicine and make a difference in the world. Since our inception in 1990, we’ve partnered with pharmaceutical, biotech, and medical device clients, collaborating, innovating, and finding new ...
15 ott 2021 · ICON offers clinical research services which include consulting, clinical development and commercialization across a wide range of therapeutic areas. In 2021, ICON acquired PRA Health Sciences, which is another CRO and global leader in clinical research services. Some clinical trial solutions offered by ICON: Commercial Positioning; Consulting
Clinical, consulting and commercial services. ICON offers a broad range of specialised services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. Our services span the entire lifecycle of product development and can be adapted to suit small local trials or large global programs.
ICON is the world's leading clinical research organisation, providing outsourced clincal development and commercialisation services to the pharmaceutical, biotechnology and medical device industries.
ICON Careers. We encourage our people to seize the opportunity to bring flexibility, innovation and determination to every situation. By doing this, our people build exciting and rewarding careers, deliver results to help bring life-changing medicines and devices to market and maintain ICON’s success as an industry leader. View jobs at ICON
About ICON. Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We are a global provider of consulting, and outsourced development and commercialisation services to pharmaceutical, biotechnology, medical device ...
